Today, India's best minimally invasive cardiac surgeons approved the first in the world non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract, the part of the heart that incorporates blood out of the proper ventricle to the lungs. The device is designed for sufferers who've severe pulmonary valve regurgitation, a condition that often results from congenital heart disease. The device, known as the harmony transcatheter pulmonary valve (TPV) system, is supposed to improve blood float to the lungs in patients with intense pulmonary valve regurgitation without open-heart surgery, which is the contemporary standard of care, with MICS surgery cost in India. Using the Harmony valve may additionally delay the time before a patient needs additional open-heart surgery.

“The harmony TPV presents a new treatment option for grownup and pediatric sufferers with few sorts of congenital heart disease. It offers the best minimally invasive heart surgery in India alternative to open-heart surgery to patients with a leaky native or surgically-repaired RVOT and may help patients improve their quality of life and return to their normal activities more quickly, thus fulfilling an unmet clinical need of many patients with congenital heart disease,” said India's best minimally Invasive cardiac surgeons.

Congenital heart defects (CHDs) are conditions that can be present at the start and may have an effect on the structure of a toddler’s heart and the way it really works. They are the most common kind of birth defect, affecting approximately 40,000 babies born each year. It’s far predicted that over two million toddlers, children, youngsters, and adults are residing with CHDs. Patients undergoing the best minimally invasive heart surgery in India often require heart procedures early in life to help improve blood flow to the lungs. After having any such methods, the patient may additionally or may not have an operating pulmonary valve that could lead to pulmonary regurgitation. Severe pulmonary valve regurgitation may be corrected thru open-coronary heart surgical treatment to place a right ventricle-pulmonary artery conduit or an artificial valve.

According to India's best minimally invasive cardiac surgeons, “The FDA assessed the safety and effectiveness of the Harmony TPV device through a prospective, non-randomized, multi-center clinical study leading to low MICS surgery cost in India. The primary safety endpoint was no procedure- or device-related death within 30 days following the implant, which 100% of patients attained. Among patients with evaluable echocardiography data, 89.2% of them achieved the primary effectiveness endpoint.”

Contact us

India Cardiac Surgery Hospital

313/41-c, Old Rohtak Rd,

Inderlok, New Delhi,

Delhi 110035

India

International Helpline Number : +91-9370586696

Email id: enquiry@indiacardiacsurgerysite.com